Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Gels ; 9(3)2023 Mar 11.
Artigo em Inglês | MEDLINE | ID: mdl-36975664

RESUMO

The effect of black tea powder on the antioxidant activity and gel characteristics of fish balls from silver carp were investigated after freezing storage for 7 days. The results show that black tea powder with different concentrations of 0.1%, 0.2% and 0.3% (w/w) could significantly increase the antioxidant activity of fish balls (p < 0.05). In particular, at the concentration of 0.3%, the antioxidant activity was the strongest among these samples, where the reducing power, DPPH, ABTS and OH free radical scavenging rate were up to 0.33, 57.93%, 89.24% and 50.64%, respectively. In addition, black tea powder at the level of 0.3% significantly increased the gel strength, hardness and chewiness while greatly reducing the whiteness of the fish balls (p < 0.05). ESEM observation found that the addition of black tea powder could promote the crosslinking of proteins and reduced the pore size of the gel network structure of the fish balls. The results suggest that black tea powder could be used as a natural antioxidant and gel texture enhancer in fish balls, which we found to be much related to the phenolic compounds of black tea powder.

2.
Food Sci Nutr ; 10(11): 3759-3771, 2022 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-36348786

RESUMO

Phosphate is widely used in surimi products to improve the gel properties. However, excess addition of phosphate occurs, which can harm the consumer's health. This study aimed to evaluate the effects of agar gum and fucoidan on maintaining the gel properties of surimi products instead of phosphate. Interestingly, our results showed that 0.125% of agar gum and fucoidan to replace phosphate could enhance water-holding capacity and maintain gel strength and textual properties of surimi products well. Especially at frozen storage for 1 year, 0.125% of agar gum reduced the expressible moisture content of surimi products by around 10% (p < .05). Sensory evaluation showed that 0.125% of agar gum and fucoidan instead of phosphate can improve tissue and fondness of surimi products in refrigerated storage for 24 h but not in frozen storage for 1 year. The addition of agar gum and fucoidan at a high concentration >0.50% increased the WHC, but significantly decreased gel strength and springiness of surimi products (p < .05). Particularly, 1.00% of agar gum and fucoidan reduced gel strength by around 20% (p < .05). It might be due to the destruction of the gel network structure of surimi protein following the excess addition of these polysaccharides. It can be concluded that 0.125% of agar gum and fucoidan can replace phosphate to develop high-quality surimi products, and excessive addition of them have negative effects.

3.
Polymers (Basel) ; 14(3)2022 Jan 27.
Artigo em Inglês | MEDLINE | ID: mdl-35160507

RESUMO

Pomelo fruitlets have the potential for extracting cellulose. This study aimed to investigate characterization and functionality of cellulose extracted from pomelo fruitlets by different extraction methods. Cellulose extracted by acidic-alkaline hydrogen peroxide hydrolysis (CAA), alkaline hydrogen peroxide hydrolysis (CA), and ultrasonic assisted alkaline hydrogen peroxide hydrolysis (CUA) were prepared from pomelo fruitlets. The results showed that cellulose CUA had higher yield and purity with higher crystallinity and smaller particle size than those of CAA or CA (p < 0.05). Specifically, the yield of CUA was 82.75% higher than that of CAA, and purity was increased by 26.42%. Additionally, water- and oil-holding capacities of CUA were superior to those of CAA or CA, increasing by 13-23% and 10-18%, respectively. The improvement of water- and oil-holding capacities were highly related to its smaller particle size with increased surface area. The results suggested that ultrasonic assisted alkaline hydrogen peroxide hydrolysis is a promising and efficient method to prepare high-purity cellulose from pomelo fruitlets, and this cellulose is expected to be a food stabilizer and pharmaceutical additive.

4.
Int J Biochem Cell Biol ; 110: 1-8, 2019 05.
Artigo em Inglês | MEDLINE | ID: mdl-30710754

RESUMO

BACKGROUND: Immunotherapy is a promising method for the treatment of hepatocellular carcinoma (HCC), in which CD8+T cells play a key role. The influence of long noncoding RNA (lncRNA) nuclear-enriched autosomal transcript 1(NEAT1) on the antitumor activity of CD8+T cells was clarified in this study. METHODS: Peripheral blood mononuclear cells (PBMCs) were isolated from HCC patients, and the expressions of NEAT1 and Tim-3 were determined by qRT-PCR and western blot, respectively. CD8+T cell apoptosis and cell percentage were analyzed via flow cytometry. The cytolysis activity of CD8+T cells against HCC cells was examined. RNA immunoprecipitation (RIP) and RNA pull-down assay were performed to explore the interaction between NEAT1 and miR-155. RESULTS: NEAT1 and Tim-3 were up-regulated in the PBMCs of patients with HCC (n = 20) compared with healthy subjects (n = 20). Down-regulation of NEAT1 restrained CD8+T cell apoptosis and enhanced the cytolysis activity, while interference of miR-155 showed the opposite effects by up-regulating Tim-3. Binding and interaction between NEAT1 and miR-155 were validated in CD8+T cells. Down-regulation of NEAT1 restrained CD8+T cell apoptosis and enhanced the cytolysis activity through the miR-155/Tim-3 pathway. Repression of NEAT1 suppressed tumor growth in HCC mice. CONCLUSION: Via modulating the miR-155/Tim-3 pathway, repression of NEAT1 restrained CD8+T cell apoptosis and enhanced the cytolysis activity against HCC, implying an effective target for improving the outcome of immunotherapy.


Assuntos
Linfócitos T CD8-Positivos/imunologia , Carcinoma Hepatocelular/imunologia , Receptor Celular 2 do Vírus da Hepatite A/genética , Neoplasias Hepáticas/imunologia , MicroRNAs/genética , RNA Longo não Codificante/genética , Apoptose/genética , Sequência de Bases , Linfócitos T CD8-Positivos/citologia , Linfócitos T CD8-Positivos/metabolismo , Carcinoma Hepatocelular/genética , Carcinoma Hepatocelular/patologia , Proliferação de Células/genética , Feminino , Humanos , Imunoterapia , Neoplasias Hepáticas/genética , Neoplasias Hepáticas/patologia , Masculino , Pessoa de Meia-Idade , Regulação para Cima/genética
5.
Zhonghua Bing Li Xue Za Zhi ; 41(6): 386-90, 2012 Jun.
Artigo em Chinês | MEDLINE | ID: mdl-22932406

RESUMO

OBJECTIVE: To investigate the relationship between secondary mutations of c-kit/PDGFRα resistance to imatinib mesylate and the efficacy of sunitinib in patients with gastrointestinal stromal tumor (GIST). METHODS: Five pairs specimens were collected before and after imatinib mesylate resistance. DNA for molecular genetic investigation was extracted from formalin-fixed, paraffin-embedded tissues. Mutational analysis was performed by using PCR and direct sequencing. RESULTS: Five pairs of specimens were collected before and after imatinib mesylate resistance from 5 GIST patients. C-kit exon 11 mutations were detected in 3 patients, which were all acquired mutations, including c-kit exon 13 V654A, c-kit exon 13 V654E and c-kit exon 17 N822K, after imatinib mesylate resistance. Furthermore, after sunitinib treatment, 3 patients had stable disease and progression free survival (PFS) were 3.5 months, 4.4 months and 3.8 months, respectively. C-kit exon 9 mutations were detected in 2 patients with no acquired mutations after imatinib mesylate resistance. And the both had partial response from sunitinib, following with 13.1 months and 12.0 months PFS respectively. CONCLUSION: The c-kit/PDGFRα genotypes after imatinib mesylate resistance may both relate to primary mutations and efficacy of sunitinib treatment.


Assuntos
Tumores do Estroma Gastrointestinal/genética , Indóis/uso terapêutico , Mutação , Proteínas Proto-Oncogênicas c-kit/genética , Pirróis/uso terapêutico , Receptor alfa de Fator de Crescimento Derivado de Plaquetas/genética , Antineoplásicos/uso terapêutico , Benzamidas , Intervalo Livre de Doença , Resistencia a Medicamentos Antineoplásicos , Éxons , Feminino , Tumores do Estroma Gastrointestinal/tratamento farmacológico , Genótipo , Humanos , Mesilato de Imatinib , Masculino , Pessoa de Meia-Idade , Piperazinas/uso terapêutico , Proteínas Proto-Oncogênicas c-kit/metabolismo , Pirimidinas/uso terapêutico , Receptor alfa de Fator de Crescimento Derivado de Plaquetas/metabolismo , Sunitinibe
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...